ChrysCapital raises $2.2B in India's largest private equity fund
What's the story
ChrysCapital has made history by raising a whopping $2.2 billion for its latest fund, ChrysCapital X. The Indian private equity firm achieved this milestone with the support of global and domestic investors alike. The new fund is a significant jump from the $1.35 billion raised for Fund IX in 2022, marking an over 60% increase in capital raised within just one year.
Investment focus
ChrysCapital's investment strategy and track record
ChrysCapital's investment strategy is focused on key sectors such as consumer goods, healthcare, and technology. The firm has a proven track record of delivering substantial returns to its investors. Since its inception in 1999, ChrysCapital has raised nearly $8.5 billion across 10 private equity funds and a public markets fund. It has also invested over $5.5 billion in more than 110 portfolio companies through these funds.
Exit strategy
Successful exits and returns to investors
ChrysCapital has successfully exited from over 80 investments, returning nearly $7.8 billion to its investors at a 3x return on investment (ROI). The firm's successful exits include companies like Intas Pharmaceuticals, Mankind Pharma, GeBBS Healthcare, Infogain, the National Stock Exchange, and Awfis. The firm has also seen strong returns from its investments in the pharmaceuticals and healthcare sectors with returns ranging from 3-9x.
Investor diversity
New global investors join the fold
For its latest fund, ChrysCapital added over 30 new global investors, including public pension funds, insurance companies, asset management firms, family offices, and other institutional investors from Japan, the Middle East, Southeast Asia, Europe, and the US. The firm also raised capital from Indian investors for the first time with strong participation from institutional investors as well as large family offices.